Cargando…
Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
Data were collected from 39 newborn screening (NBS) programs to provide insight into the time and factors required for implementing statewide screening for Pompe, Mucopolysaccharidosis type I (MPS I), adrenoleukodystrophy (ALD), and Spinal Muscular Atrophy (SMA). Newborn screening program readiness...
Autores principales: | Kellar-Guenther, Yvonne, McKasson, Sarah, Hale, Kshea, Singh, Sikha, Sontag, Marci K., Ojodu, Jelili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422992/ https://www.ncbi.nlm.nih.gov/pubmed/33073030 http://dx.doi.org/10.3390/ijns6020035 |
Ejemplares similares
-
Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation
por: Hale, Kshea, et al.
Publicado: (2020) -
Development of National Newborn Screening Quality Indicators in the United States
por: Yusuf, Careema, et al.
Publicado: (2019) -
Analyzing Patterns in NewSTEPs Site Review Recommendations: Practical Applications for Newborn Screening Programs
por: Kellar-Guenther, Yvonne, et al.
Publicado: (2019) -
Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021
por: Hale, Kshea, et al.
Publicado: (2021) -
Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository
por: Sontag, Marci K., et al.
Publicado: (2020)